File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: SARS: Future research and vaccine

TitleSARS: Future research and vaccine
Authors
KeywordsAntiviral
Coronavirus
SARS
Vaccine
Issue Date2004
PublisherWB Saunders Co Ltd. The Journal's web site is located at http://www.elsevier.com/locate/prrv
Citation
Paediatric Respiratory Reviews, 2004, v. 5 n. 4, p. 300-303 How to Cite?
AbstractSevere acute respiratory syndrome (SARS) is a new infectious disease of the 21st century that has pandemic potential. A novel coronavirus (CoV) was identified as its aetiological agent and its genome was sequenced within months of the World Health Organisation issuing a global threat on SARS. The high morbidity and mortality of this potentially pandemic infection demands a rapid research response to develop effective antiviral treatment and vaccine. This will depend on understanding the pathogenesis and immune response to SARS CoV. Further understanding of the ecology of SARS CoV in human and animals will help prevent future cross species transmission. Likewise for the super-spreading events, clarification of the underlying reasons will be important to prevent a large scale outbreak of SARS. Lastly it is of utmost importance that international research collaboration should be strengthened to deal with SARS and any other emerging infectious disease that can seriously threaten our future. © 2004 Elsevier Ltd. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/79816
ISSN
2015 Impact Factor: 2.536
2015 SCImago Journal Rankings: 0.734
References

 

DC FieldValueLanguage
dc.contributor.authorLau, YLen_HK
dc.date.accessioned2010-09-06T07:59:04Z-
dc.date.available2010-09-06T07:59:04Z-
dc.date.issued2004en_HK
dc.identifier.citationPaediatric Respiratory Reviews, 2004, v. 5 n. 4, p. 300-303en_HK
dc.identifier.issn1526-0542en_HK
dc.identifier.urihttp://hdl.handle.net/10722/79816-
dc.description.abstractSevere acute respiratory syndrome (SARS) is a new infectious disease of the 21st century that has pandemic potential. A novel coronavirus (CoV) was identified as its aetiological agent and its genome was sequenced within months of the World Health Organisation issuing a global threat on SARS. The high morbidity and mortality of this potentially pandemic infection demands a rapid research response to develop effective antiviral treatment and vaccine. This will depend on understanding the pathogenesis and immune response to SARS CoV. Further understanding of the ecology of SARS CoV in human and animals will help prevent future cross species transmission. Likewise for the super-spreading events, clarification of the underlying reasons will be important to prevent a large scale outbreak of SARS. Lastly it is of utmost importance that international research collaboration should be strengthened to deal with SARS and any other emerging infectious disease that can seriously threaten our future. © 2004 Elsevier Ltd. All rights reserved.en_HK
dc.languageengen_HK
dc.publisherWB Saunders Co Ltd. The Journal's web site is located at http://www.elsevier.com/locate/prrven_HK
dc.relation.ispartofPaediatric Respiratory Reviewsen_HK
dc.subjectAntiviralen_HK
dc.subjectCoronavirusen_HK
dc.subjectSARSen_HK
dc.subjectVaccineen_HK
dc.titleSARS: Future research and vaccineen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1526-0542&volume=5&spage=300&epage=303&date=2004&atitle=SARS:+future+research+and+vaccineen_HK
dc.identifier.emailLau, YL:lauylung@hkucc.hku.hken_HK
dc.identifier.authorityLau, YL=rp00361en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.prrv.2004.07.005en_HK
dc.identifier.pmid15531254-
dc.identifier.scopuseid_2-s2.0-7744236697en_HK
dc.identifier.hkuros96409en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-7744236697&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume5en_HK
dc.identifier.issue4en_HK
dc.identifier.spage300en_HK
dc.identifier.epage303en_HK
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridLau, YL=7201403380en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats